Literature DB >> 25462220

Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.

Dakshina U Ganihigama1, Sanya Sureram2, Sasithorn Sangher2, Poonpilas Hongmanee3, Thammarat Aree4, Chulabhorn Mahidol5, Somsak Ruchirawat6, Prasat Kittakoop7.   

Abstract

Various classes of natural products and synthetic compounds were tested against reference strains and clinical multidrug resistant isolates of Mycobacterium tuberculosis. Vermelhotin (19), a natural tetramic acid from fungi, was the most active toward clinical MDR TB isolates (MIC 1.5-12.5 μg/mL). Synthetic compounds (i.e. benzoxazocines, coumarins, chromenes, and pyrrolodiquinoline derivatives) were prepared by green chemistry approaches. Under microwave irradiation, a one-pot synthesis of pyrrolodiquinoline 85 was achieved by homocoupling of 1-methylquinolinium iodide; the structure of 85 was confirmed by single-crystal X-ray analysis. Compound 85 and its derivative 86 exhibited potent anti-tubercular activity (MIC 0.3-6.2 μg/mL) against clinical MDR TB isolates, and they displayed weak cytotoxicity toward normal cell line. The scaffold of 85 and 86 is potential for antimycobacterial activity.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antimycobacterial activity; Antimycobacterial compound; Microwave-assisted synthesis; Multidrug resistant tuberculosis; Mycobacterium tuberculosis; Natural product

Mesh:

Substances:

Year:  2014        PMID: 25462220     DOI: 10.1016/j.ejmech.2014.10.026

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  9 in total

Review 1.  Southeast Asian Medicinal Plants as a Potential Source of Antituberculosis Agent.

Authors:  Shuaibu Babaji Sanusi; Mohd Fadzelly Abu Bakar; Maryati Mohamed; Siti Fatimah Sabran; Muhammad Murtala Mainasara
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-03       Impact factor: 2.629

2.  Antimycobacterial, Enzyme Inhibition, and Molecular Interaction Studies of Psoromic Acid in Mycobacterium tuberculosis: Efficacy and Safety Investigations.

Authors:  Sherif T S Hassan; Miroslava Šudomová; Kateřina Berchová-Bímová; Shanmugaraj Gowrishankar; Kannan R R Rengasamy
Journal:  J Clin Med       Date:  2018-08-20       Impact factor: 4.241

Review 3.  The Biological and Chemical Diversity of Tetramic Acid Compounds from Marine-Derived Microorganisms.

Authors:  Minghua Jiang; Senhua Chen; Jing Li; Lan Liu
Journal:  Mar Drugs       Date:  2020-02-15       Impact factor: 5.118

4.  Synthesis, computational studies, antimycobacterial and antibacterial properties of pyrazinoic acid-isoniazid hybrid conjugates.

Authors:  Siva S Panda; Adel S Girgis; Bibhuti B Mishra; Mohamed Elagawany; Venkatasai Devarapalli; William F Littlefield; Ahmed Samir; Walid Fayad; Nehmedo G Fawzy; Aladdin M Srour; Riham M Bokhtia
Journal:  RSC Adv       Date:  2019-07-01       Impact factor: 4.036

5.  Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.

Authors:  Katharigatta N Venugopala; Sandeep Chandrashekharappa; Pran Kishore Deb; Christophe Tratrat; Melendhran Pillay; Deepak Chopra; Nizar A Al-Shar'i; Wafa Hourani; Lina A Dahabiyeh; Pobitra Borah; Rahul D Nagdeve; Susanta K Nayak; Basavaraj Padmashali; Mohamed A Morsy; Bandar E Aldhubiab; Mahesh Attimarad; Anroop B Nair; Nagaraja Sreeharsha; Michelyne Haroun; Sheena Shashikanth; Viresh Mohanlall; Raghuprasad Mailavaram
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

6.  Phytogenic silver, gold, and bimetallic nanoparticles as novel antitubercular agents.

Authors:  Richa Singh; Laxman Nawale; Manisha Arkile; Sweety Wadhwani; Utkarsha Shedbalkar; Snehal Chopade; Dhiman Sarkar; Balu Ananda Chopade
Journal:  Int J Nanomedicine       Date:  2016-05-04

7.  Effects of the encapsulation of usnic acid into liposomes and interactions with antituberculous agents against multidrug-resistant tuberculosis clinical isolates.

Authors:  Rafaela S Ferraz-Carvalho; Marcela A Pereira; Leonardo A Linhares; Mariane Cb Lira-Nogueira; Isabella Mf Cavalcanti; Nereide S Santos-Magalhães; Lílian Ml Montenegro
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-04-29       Impact factor: 2.743

8.  Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity.

Authors:  Guilherme Felipe Dos Santos Fernandes; Paula Carolina de Souza; Elsa Moreno-Viguri; Mery Santivañez-Veliz; Rocio Paucar; Silvia Pérez-Silanes; Konstantin Chegaev; Stefano Guglielmo; Loretta Lazzarato; Roberta Fruttero; Chung Man Chin; Patricia Bento da Silva; Marlus Chorilli; Mariana Cristina Solcia; Camila Maríngolo Ribeiro; Caio Sander Paiva Silva; Leonardo Biancolino Marino; Priscila Longhin Bosquesi; Debbie M Hunt; Luiz Pedro S de Carvalho; Carlos Alberto de Souza Costa; Sang Hyun Cho; Yuehong Wang; Scott Gary Franzblau; Fernando Rogério Pavan; Jean Leandro Dos Santos
Journal:  J Med Chem       Date:  2017-10-16       Impact factor: 7.446

9.  Analysis of Approaches to Anti-tuberculosis Compounds.

Authors:  Sara Motamen; Ronald J Quinn
Journal:  ACS Omega       Date:  2020-10-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.